| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:snss | nasdaq:snss Shareholders | 13F-HR | 0001507673-21-000006 | Dec 31st, 2020 12:00AM | Feb 16th, 2021 12:00AM | Feb 16th, 2021 12:00AM | RP Management, LLC | 1507673 | SUNESIS PHARMACEUTICALS INC | COM NEW | 867328700 | 26 | 129517 | SH | DFND | 1 | 129517 | 0 | 0 | May 4th, 2022 07:23AM | May 4th, 2022 07:23AM | Sunesis Pharmaceuticals | Pharmaceuticals & Biotechnology | ||
| nasdaq:snss | nasdaq:snss Shareholders | 13F-HR | 0001306923-21-000016 | Dec 31st, 2020 12:00AM | Feb 16th, 2021 12:00AM | Feb 16th, 2021 12:00AM | Palo Alto Investors LP | 1306923 | SUNESIS PHARMACEUTICALS INC | COM | 867328700 | 231 | 116246 | SH | SOLE | 0 | 116246 | 0 | 0 | May 4th, 2022 07:21AM | May 4th, 2022 07:21AM | Sunesis Pharmaceuticals | Pharmaceuticals & Biotechnology | ||
| nasdaq:snss | nasdaq:snss Shareholders | 13F-HR | 0001012975-21-000080 | Dec 31st, 2020 12:00AM | Feb 16th, 2021 12:00AM | Feb 16th, 2021 12:00AM | NEA Management Company, LLC | 1512848 | SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 258 | 129827 | SH | DFND | 129827 | 0 | 0 | May 4th, 2022 07:14AM | May 4th, 2022 07:14AM | Sunesis Pharmaceuticals | Pharmaceuticals & Biotechnology | |||
| nasdaq:snss | nasdaq:snss Shareholders | 13F-HR/A | 0001766721-21-000003 | Dec 31st, 2020 12:00AM | Feb 5th, 2021 12:00AM | Feb 5th, 2021 12:00AM | Aisling Capital Management LP | 1766721 | Sunesis Pharmaceuticals, Inc. (SNSS) | COM | 867328700 | 2010 | 1010000 | SH | SOLE | 1010000 | 0 | 0 | May 4th, 2022 05:56AM | May 4th, 2022 05:56AM | Sunesis Pharmaceuticals | Pharmaceuticals & Biotechnology | |||
| nasdaq:snss | nasdaq:snss Shareholders | 13F-HR | 0001766721-21-000002 | Dec 31st, 2020 12:00AM | Feb 4th, 2021 12:00AM | Feb 4th, 2021 12:00AM | Aisling Capital Management LP | 1766721 | Sunesis Pharmaceuticals, Inc. (SNSS) | COM | 867328700 | 2010 | 1010000 | SH | SOLE | 1010000 | 0 | 0 | May 4th, 2022 05:48AM | May 4th, 2022 05:48AM | Sunesis Pharmaceuticals | Pharmaceuticals & Biotechnology | |||
| nasdaq:snss | nasdaq:snss Shareholders | 13F-HR | 0001633697-21-000001 | Dec 31st, 2020 12:00AM | Jan 13th, 2021 12:00AM | Jan 13th, 2021 12:00AM | Sowell Financial Services LLC | 1633697 | SUNESIS PHARMACEUTICALS INC COM NEW | COM | 867328700 | 30 | 15000 | SH | SOLE | 15000 | 0 | 0 | May 4th, 2022 04:17AM | May 4th, 2022 04:17AM | Sunesis Pharmaceuticals | Pharmaceuticals & Biotechnology | |||
| nasdaq:snss | nasdaq:snss Shareholders | 13F-HR | 0001537055-18-000009 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Telemetry Investments, L.L.C. | 1537055 | SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 102 | 50759 | SH | SOLE | 50759 | 0 | 0 | Dec 8th, 2021 01:27PM | Dec 8th, 2021 01:27PM | Sunesis Pharmaceuticals | Pharmaceuticals & Biotechnology | |||
| nasdaq:snss | nasdaq:snss Shareholders | 13F-HR | 0001493152-18-015893 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | BOOTHBAY FUND MANAGEMENT, LLC | 1549230 | SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 100 | 50209 | SH | SOLE | 50209 | 0 | 0 | Dec 8th, 2021 01:26PM | Dec 8th, 2021 01:26PM | Sunesis Pharmaceuticals | Pharmaceuticals & Biotechnology | |||
| nasdaq:snss | nasdaq:snss Shareholders | 13F-HR | 0001442891-18-000008 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | EVENTIDE ASSET MANAGEMENT, LLC | 1442891 | SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 4531 | 2265455 | SH | SOLE | 0 | 2265455 | 0 | 0 | Dec 8th, 2021 01:25PM | Dec 8th, 2021 01:25PM | Sunesis Pharmaceuticals | Pharmaceuticals & Biotechnology | ||
| nasdaq:snss | nasdaq:snss Shareholders | 13F-HR | 0001389933-18-000012 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | DAFNA Capital Management LLC | 1389933 | SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 747 | 373702 | SH | SOLE | 373702 | 0 | 0 | Dec 8th, 2021 01:24PM | Dec 8th, 2021 01:24PM | Sunesis Pharmaceuticals | Pharmaceuticals & Biotechnology |